Rudi Vennekens

Professor

KU Leuven
Country flagBelgium

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Rudi Vennekens is a Professor at KU Leuven in Belgium. His research focuses on the role of TRPM4 ion channels in cardiac arrhythmias, kidney physiology, and their implications in diseases such as autosomal dominant polycystic kidney disease. He has published various articles exploring calcium signaling, the apelinergic system, and the pharmacokinetics of compounds affecting glucose homeostasis.

Articles (13)

Year:

2027

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease. Cysts develop through dedifferentiation of tubular epithelial cells, but the sequence of molecular events and their relative importance remain unclear. To address this gap in knowledge, 40 cysts from 4 ADPKD kidneys and 4 microcystic tissues were mapped on transcriptomic and histological level. Cyst were heterogenous and we identified 6 cystic subclusters with 2 deviations from the main trajectory, dependent on the rate of interstitial remodeling, inflammation and dedifferentiation. Loss of proximal tubular marker gene expression was more pronounced compared to those of other tubular segments. Altered expression of metabolic pathways was consistent among the cysts, which was further analyzed in human and mouse cell lines. Purine metabolism was similarly altered in all ADPKD cell lines, and its modulation with azathioprine suppressed cyst formation in vitro. In conclusion, by focusing on common altered pathways in cysts and cell models, we have identified purine metabolism as a novel potential target in ADPKD.

Year:

2025

Transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated non-selective cation channel that regulates various physiological functions of excitable cells. In accordance with our previous findings, TRPM4 is known to be present and to be functionally active in hilar mossy cells where it controls seizure susceptibility. With the help of in vivo and in vitro electrophysiological and histological experiments, we investigated the effect of TRPM4 channel inhibition upon kainic acid–induced seizures. In this study, we present that in vivo administration of meclofenamate a novel blocker of TRPM4 before kainic acid injection reduces both seizure frequency and duration in mice. Furthermore, our findings reveal that meclofenamate treatment prior to kainic acid injection selectively reduced mossy cell loss in the ventral hippocampus. Interestingly, we observed elevated expression of TRPM4 in mossy cells of the ventral hippocampus highlighting the heterogenity of these neurons in the hippocampus. In addition, patch clamp recordings revealed that meclofenamate modulates both the spontaneous activity and the action potential dynamics of mossy cells. Lastly, we revealed the presence of TRPM4 transcript in human mossy cells. Altogether, these findings suggest that pharmacological inhibition of TRPM4 may reduce seizure frequency thus possibly protect mossy cells.

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Djalila Mekahli

-

BELGIUM
View details

Abhishek Garg

Professor at KU Leuven

KU Leuven

BELGIUM
View details

Erwin Adams

Professor

KU Leuven

BELGIUM
View details

Ann Van Schepdael

-

BELGIUM
View details

Balázs Gaszner

University of Pecs

HUNGARY
View details